Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

Jan 29, 2019

Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock

Jan 25, 2019

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

Jan 24, 2019

Interpace Diagnostics to Present at the Fifteenth Annual NobleCon

Jan 24, 2019

Interpace Diagnostics Announces Further Expansion of Thyroid Business

Jan 22, 2019

Interpace Diagnostics Enters into Agreement with University of Maryland Medical System

Jan 14, 2019

Interpace Diagnostics Ranked as Top 10 Bioinformatics Solutions Provider

Dec 27, 2018

Interpace Announces Notice of Allowance from U.S. Patent and Trademark Office Covering BarreGEN®

Dec 17, 2018

Interpace Diagnostics Launches New Websites

Nov 28, 2018

Newly Published Data from National Study Supports Interpace Diagnostics’ PancraGEN®

Nov 26, 2018